Meyerhoff Dieter J
Center for Imaging of Neurodegenerative Diseases, San Francisco Veterans Affairs Medical Center, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Handb Clin Neurol. 2014;125:313-37. doi: 10.1016/B978-0-444-62619-6.00019-7.
This chapter critically reviews brain proton magnetic resonance spectroscopy ((1)H MRS) studies performed since 1994 in individuals with alcohol use disorders (AUD). We describe the neurochemicals that can be measured in vivo at the most common magnetic field strengths, summarize our knowledge about their general brain functions, and briefly explain some basic human (1)H MRS methods. Both cross-sectional and longitudinal research of individuals in treatment and of treatment-naïve individuals with AUD are discussed and interpreted on the basis of reported neuropathology. As AUDs are highly comorbid with chronic cigarette smoking and illicit substance abuse, we also summarize reports on their respective influences on regional proton metabolite levels. After reviewing research on neurobiologic correlates of relapse and genetic influences on brain metabolite levels, we finish with suggestions on future directions for (1)H MRS studies in AUDs. The review demonstrates that brain metabolic alterations associated with AUDs as well as their cognitive correlates are not simply a consequence of chronic alcohol consumption. Future MR research of AUDs in general has to be better prepared - and supported - to study clinically complex relationships between personality characteristics, comorbidities, neurogenetics, lifestyle, and living environment, as all these factors critically affect an individual's neurometabolic profile. (1)H MRS is uniquely positioned to tackle these complexities by contributing to a comprehensive biopsychosocial profile of individuals with AUD: it can provide non-invasive biochemical information on select regions of the brain at comparatively low overall cost for the ultimate purpose of informing more efficient treatments of AUDs.
本章批判性地回顾了自1994年以来对酒精使用障碍(AUD)个体进行的脑质子磁共振波谱((1)H MRS)研究。我们描述了在最常见磁场强度下可在体内测量的神经化学物质,总结了我们对其一般脑功能的了解,并简要解释了一些基本的人体(1)H MRS方法。基于已报道的神经病理学,对接受治疗的个体以及未接受过治疗的AUD个体的横断面和纵向研究进行了讨论和解释。由于AUD与慢性吸烟和非法药物滥用高度共病,我们还总结了关于它们各自对区域质子代谢物水平影响的报告。在回顾了关于复发的神经生物学相关性以及基因对脑代谢物水平影响的研究后,我们最后提出了AUD中(1)H MRS研究未来方向的建议。该综述表明,与AUD相关的脑代谢改变及其认知相关性并非仅仅是长期饮酒的结果。总体而言,未来对AUD的磁共振研究必须做好更充分的准备并获得支持,以研究人格特征、共病、神经遗传学、生活方式和生活环境之间临床上复杂的关系,因为所有这些因素都会严重影响个体的神经代谢特征。(1)H MRS在通过为AUD个体提供全面的生物心理社会概况方面具有独特的地位:它可以以相对较低的总体成本提供关于大脑特定区域的非侵入性生化信息,最终目的是为更有效的AUD治疗提供依据。